The Cell Line Characterization Market Size is valued at USD 378.96 Mn in 2023 and is predicted to reach USD 651.34 Mn by the year 2031 at an 7.25% CAGR during the forecast period for 2024-2031.
Cell line characterization is crucial in developing and producing biologics, ensuring the identity, purity, and genetic stability of cell lines used in research and therapeutic applications. This process is essential for complying with regulatory standards and ensuring the safety of biopharmaceutical products. Derived from a single cell and cultured in laboratories, cell lines are fundamental research tools with various applications, including vaccine and antibody production and the synthesis of biological compounds. The growing promise of biopharmaceuticals for treating hard-to-treat conditions, such as immunological, oncological, and rare disorders, has garnered significant interest from industry and academic stakeholders.
Characterization involves confirming the species of origin, assessing purity for contaminants, and evaluating genetic stability throughout the production process. This ensures that cell lines maintain their characteristics over time and are suitable for research and therapeutic use. As the biopharmaceutical industry continues to develop new therapies, the demand for reliable and well-characterized cell lines will increase. Cell line characterization services will be crucial in ensuring these therapies' safety and efficacy, driving market growth in the coming years.
The cell line characterization market is segmented by application, end user, and cell line type. By application the market is segmented into cell line identity, genetic stability, viral and microbial contamination, others. By end user market is categorized into pharmaceutical and biotechnology companies, academic and research institutes, and others. By cell line type market is categorized into mammalian, microbial, and insect cell.
The mammalian cell line segment drives the cell line characterization market due to its crucial role in biopharmaceutical development. These cell lines are preferred for producing complex, human-like proteins essential for effective chronic disease and cancer therapies. Strict regulatory guidelines have increased the need for thorough characterization, driving investment in these services. Technological advancements in cell culture, such as automation and improved media, have made mammalian cell line development more efficient. The biopharmaceutical industry's growth, fueled by the prevalence of chronic diseases and personalized medicine demand, further boosts the adoption of mammalian cell lines in research and production.
The Cell Line Identity segment is experiencing significant growth within the Cell Line Characterization Market due to several key factors. Increasing regulatory standards mandate stringent cell line authentication and validation to prevent cross-contamination, misidentification, and genetic drift, driving demand for identity characterization services. The expanding biopharmaceutical industry, developing monoclonal antibodies, vaccines, and gene therapies, relies heavily on well-characterized cell lines to ensure therapy safety and efficacy. Additionally, technological advancements like next-generation sequencing enhance the accuracy and efficiency of identity verification, encouraging more organizations to invest in these services.
North America leads the cell line characterization market, driven by its strong biopharmaceutical sector, particularly in the United States, which generates high demand for these services. The region's advanced research infrastructure, comprising numerous academic institutions and research organizations, supports innovative therapy and biologics development. Additionally, stringent regulatory standards necessitate accurate cell line identity verification, prompting North American companies to invest in compliance, further boosting the market.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 378.96 Mn |
|
Revenue Forecast In 2031 |
USD 651.34 Mn |
|
Growth Rate CAGR |
CAGR of 7.25 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, End User, Cell Line Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Applied Genetics Laboratories, Inc., Cell Line Genetics, Inc., Charles River Laboratories, Creative Biogene, Creative BioLabs, GeneCopoeia, Merck KGaA, Patho Quest, Sartorius, SGS S.A., ATUM, Thermo Fisher Scientific, ProBioGen, KBI Biopharma, Lonza, Eurofins BioPharma Product Testing, FUJIFILM Diosynth Biotechnologies |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell Line Characterization Market Snapshot
Chapter 4. Global Cell Line Characterization Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis
5.1. by Application & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
5.2.1. Cell Line Identity
5.2.2. Genetic Stability
5.2.3. Viral and Microbial Contamination
5.2.4. Others
Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis
6.1. by End User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
6.2.1. Pharmaceutical and Biotechnology Companies
6.2.2. Academic and Research Institutes
6.2.3. Others
Chapter 7. Market Segmentation 3: by Cell Line Type Estimates & Trend Analysis
7.1. by Cell Line Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Cell Line Type:
7.2.1. Mammalian
7.2.2. Microbial
7.2.3. Insect Cell
Chapter 8. Cell Line Characterization Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.2. North America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.3. North America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Cell Line Type, 2024-2031
8.1.4. North America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.2. Europe Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.3. Europe Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Cell Line Type, 2024-2031
8.2.4. Europe Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.2. Asia Pacific Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3.3. Asia-Pacific Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Cell Line Type, 2024-2031
8.3.4. Asia Pacific Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.2. Latin America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.3. Latin America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Cell Line Type, 2024-2031
8.4.4. Latin America Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.2. Middle East & Africa Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.3. Middle East & Africa Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by Cell Line Type, 2024-2031
8.5.4. Middle East & Africa Cell Line Characterization Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Applied Genetics Laboratories, Inc.
9.2.2. Cell Line Genetics, Inc.
9.2.3. Charles River Laboratories
9.2.4. Creative Biogene
9.2.5. Creative BioLabs
9.2.6. GeneCopoeia
9.2.7. Merck KGaA
9.2.8. Patho Quest
9.2.9. Sartorius
9.2.10. SGS S.A.
9.2.11. ATUM
9.2.12. Thermo Fisher Scientific
9.2.13. ProBioGen
9.2.14. KBI Biopharma
9.2.15. Lonza
9.2.16. Eurofins BioPharma Product Testing
9.2.17. FUJIFILM Diosynth Biotechnologies
9.2.18. Other Prominent Players
Cell Line Characterization Market by Application -
Cell Line Characterization Market by End User -
Cell Line Characterization Market by Cell Line Type -
Cell Line Characterization Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
